IL6 and depressive symptom measurement: Concurrently, inflammatory cytokines involved in the pathophysiology of depression, such as IL-6 and TNF-α, directly affect bone metabolism by stimulating osteoclast activity and inhibiting osteoblast function, thereby disrupting bone homeostasis (70, 71).